Asmanex HFA (mometasone furoate)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 USE IN SPECIFIC POPULATIONS PLLR Conversion: Pregnancy Risk Summary There are no randomized clinical studies...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts